73 related articles for article (PubMed ID: 4769741)
1. Antitumor activity of cyclocytidine derivatives.
Hoshi A; Kanazawa F; Kuretani K; Kanai T; Kikugawa K
Gan; 1973 Oct; 64(5):519-22. PubMed ID: 4769741
[No Abstract] [Full Text] [Related]
2. Antitumor activity of cyclocytidine in a variety of tumors.
Hoshi A; Kanzawa F; Kuretani K
Gan; 1972 Jun; 63(3):353-60. PubMed ID: 5072834
[No Abstract] [Full Text] [Related]
3. Effect of cyclocytidine on spontaneous mammary adenocarcinoma of mice.
Tokuzen R; Kuretani K; Nakahara W
Gan; 1974 Feb; 65(1):89-91. PubMed ID: 4825393
[No Abstract] [Full Text] [Related]
4. [Treatment of acute leukemia with 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride (cyclocytidine) (author's transl)].
Masaoka T; Hasegawa Y; Tatsumi N; Nakamura H; Yoshitake J
Rinsho Ketsueki; 1973 Aug; 14(8):877-81. PubMed ID: 4797128
[No Abstract] [Full Text] [Related]
5. Letter: Proposed new derivative of cytosine arabinoside (NSC-63878) to circumvent resistance.
Cysyk RL
Cancer Chemother Rep; 1974; 58(3):298-9. PubMed ID: 4842665
[No Abstract] [Full Text] [Related]
6. Experimental study on antitumor activity and pharmacokinetics of cytosine arabinoside, cyclocytidine and BH-AC.
Takenaka T; Kimura K
Nihon Ketsueki Gakkai Zasshi; 1984 Jul; 47(4):938-49. PubMed ID: 6209907
[No Abstract] [Full Text] [Related]
7. Evaluation of retinyl palmitate and cytarabine treatment in a slowly growing rat leukemia model.
Wathne KO; Lie SO; Colly L
In Vivo; 1988; 2(2):139-41. PubMed ID: 2979829
[TBL] [Abstract][Full Text] [Related]
8. Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells.
Skipper HE; Schabel FM; Lloyd HH
Semin Hematol; 1978 Jul; 15(3):207-19. PubMed ID: 675261
[No Abstract] [Full Text] [Related]
9. Experimental and clinical studies on nucleoside analogs as antitumor agents.
Burchenal JH; Currie VE; Dowling MD; Fox JJ; Krakoff IH
Ann N Y Acad Sci; 1975 Aug; 255():202-12. PubMed ID: 1059355
[No Abstract] [Full Text] [Related]
10. Sensitivity of transplantable rat leukemia, DBLA-6, to antitumor agents.
Aoshima M; Sakurai Y
Gan; 1972 Jun; 63(3):281-90. PubMed ID: 4116213
[No Abstract] [Full Text] [Related]
11. Predictive tests in culture of drug-resistant mutants selected in vivo.
Fischer GA
Natl Cancer Inst Monogr; 1971 Dec; 34():131-4. PubMed ID: 5140860
[No Abstract] [Full Text] [Related]
12. Proceedings: Antitumor properties of amino acid related compounds. 3. Anti-leukemic effects of compounds with ethylcarbaminomethyl substituent.
Fujita H; Fukushima K; Toyoshima S
Jpn J Pharmacol; 1974; 24(0):s:35. PubMed ID: 4545744
[No Abstract] [Full Text] [Related]
13. 1,2,3,4,-Tetrahydro-1,2-diazepine derivatives: synthesis and evaluation of antileukemic activity.
Dal Piaz V; Ciciani G
Farmaco Sci; 1988 Nov; 43(11):943-9. PubMed ID: 3251787
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
Schrecker AW; Goldin A
Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
[No Abstract] [Full Text] [Related]
15. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Frei E; Schabel FM; Goldin A
Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
[No Abstract] [Full Text] [Related]
16. Preparation and antitumor activity of 4'-thio analogs of 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine.
Ototani N; Whistler RL
J Med Chem; 1974 May; 17(5):535-7. PubMed ID: 4830257
[No Abstract] [Full Text] [Related]
17. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry. (II) (author's transl)].
Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M; Suzuki I; Odashima S
Eisei Shikenjo Hokoku; 1978; (96):91-4. PubMed ID: 750052
[No Abstract] [Full Text] [Related]
18. [Selectivity of the antitumor action of 2 alkylating compounds with different carrier structures].
Astardzhieva Z; Stoichkov I
Eksp Med Morfol; 1988; 27(2):14-7. PubMed ID: 3168903
[No Abstract] [Full Text] [Related]
19. Antitumor activity of N-diazoacetyl derivatives of glycine and phenylalanine against P388 leukemia and B16 melanoma in mice.
Sava G; Giraldi T; Baldini L
Cancer Treat Rep; 1982 Jan; 66(1):179-81. PubMed ID: 6796268
[TBL] [Abstract][Full Text] [Related]
20. Relationship of structure to antitumor activity in compounds related to folic acid.
Mead JA; Wood HB; Goldin A
Cancer Chemother Rep 2; 1968 Nov; 1(2):273-361. PubMed ID: 5732302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
